Institute of Neuroscience and Physiology, Sahlgrenska Academy, Göteborg University
Gothenburg, 405 30 Göteobrg, Sweden
NCT Number: NCT00484705
Hypothesis:
The overall hypothesis is that women with PCOS, both obese and non-obese, have larger adipocytes, altered metabolism and signs of inflammation in adipose tissue and that these changes are associated with high sympathetic nerve activity, hyperandrogenism hyperinsulinaemia, insulin resistance with progression to type II diabetes and cardiovascular disease (CVD) as well as psychological distress and reduced quality of life. Physical exercise and electro-acupuncture decrease high concentrations of androgens, induce regulare menstrual pattern, inhibits high sympathetic activity and restore the PCOS induced disturbances.
Looking for future studies?
Notify Me18 year–37 year
Female
Interventional
Not applicable
Gothenburg, 405 30 Göteobrg, Sweden
Primary outcome: Changes in androgen concentrations and menstrual pattern
Secondary outcome: changes in sympathetic nerve activity, uterus peristalsis, ovarian morphology, adipose tissue related variables, insulin sensitivity, coagulation factors and health related quality of life and symptoms of anxiety and depression.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One year
Göteborg University
Other
Polycystic Ovary Syndrome (PCOS) - The Female Metabolic Syndrome Genes And Processes In The Aetiology And Pathogenesis Of PCOS And Identification Of New Treatment Strategies
Acronym: PCOSNTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03902301
46, XX Disorders of Sex Development, Adnexal Diseases
Poznan, Poland
View Trial DetailsNCT03152591
46, XX Disorders of Sex Development, Adnexal Diseases
Springfield, Missouri, United States
View Trial DetailsNCT04369248
Adnexal Diseases, Body Weight
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT00145392
Adnexal Diseases, Body Weight
Odense, Funen, Denmark
View Trial Details